Iloperidone hydrochloride
Based on 2 publication(s) in Google Scholar
Iloperidone hydrochloride (HP 873 hydrochloride) is a D2/5-HT2 receptor antagonist. Iloperidone hydrochloride is an atypical antipsychotic for the schizophrenia symptoms.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 1299470-39-5
- 화학식: C24H28ClFN2O4
- 분자량:462.94
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
제품 설명
IC50 & Target
[1]|
Rat 5-HT7 Receptor 21.6 nM (Ki) |
Rat D2 Receptor 54 nM (Ki) |
Human 5-HT2C Receptor 42.8 nM (Ki) |
Human 5-HT2A Receptor 5.6 nM (Ki) |
Human D5 Receptor 319 nM (Ki) |
Rat 5-HT6 Receptor 42.7 nM (Ki) |
Human D1 Receptor 216 nM (Ki) |
Human D4 Receptor 25 nM (Ki) |
Human D3 Receptor 7.1 nM (Ki) |
Rat 5-HT2 Receptor 3.1 nM (Ki) |
Rat D1 Receptor 546 nM (Ki) |
Rat 5-HT1A Receptor 168 nM (Ki) |
In Vitro
Iloperidone hydrochloride displays higher affinity for the dopamine D3 receptor (Ki=7.1 nM) than for the dopamine D4 receptor (Ki=25 nM). Iloperidone displays high affinity for the 5-HT6 and 5-HT7 receptors (Ki=42.7 and 21.6 nM, respectively), and is found to have higher affinity for the 5-HT2A (Ki=5.6 nM) than for the 5-HT2C receptor (Ki=42.8 nM)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 1299470-39-5
-
분자량 462.94
-
화학식 C24H28ClFN2O4
-
SMILES
CC(C1=CC=C(OCCCN2CCC(C3=NOC4=C3C=CC(F)=C4)CC2)C(OC)=C1)=O.Cl
-
Synonyms
HP 873 hydrochloride
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (2)
-
Journal Impact Factor
-
Most Recent
-
-
Neuroreport
2021 Nov 2;32(16):1299-1306. PMID: 34605450
순도&문서
References
[1]. Kongsamut, S., et al., Iloperidone binding to human and rat dopamine and 5-HT receptors. Eur J Pharmacol, 1996. 317(2-3): p. 417-23. [Content Brief]
[2]. Sainati, S.M., et al., Safety, tolerability, and effect of food on the pharmacokinetics of iloperidone (HP 873), a potential atypical antipsychotic. J Clin Pharmacol, 1995. 35(7): p. 713-20. [Content Brief]
[3]. Albers, L.J., A. Musenga, and M.A. Raggi, Iloperidone: a new benzisoxazole atypical antipsychotic drug. Is it novel enough to impact the crowded atypical antipsychotic market? Expert Opin Investig Drugs, 2008. 17(1): p. 61-75. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)